Rick is a 30-year veteran of the pharmaceutical industry, having held senior positions in Clinical Development at Merck & Co. and AstraZeneca. His career has included leading cardiovascular drug development at Merck, and leadership roles in the U.S. Business, Global Medical Sciences, and New Opportunities at AstraZeneca. At AstraZeneca, he also helped lead the effort to transform Clinical Development, focused on improving program and protocol design and the way it is linked to operational productivity.
Rick joined Quintiles in 2011, where he oversaw Biostatistics, Medical Writing, Global Regulatory Affairs, Safety Knowledge & Reporting, and global Laboratory operations. He formed the Center for Integrated Drug Development – Quintile’s home for clinical program and trial design with its enabling technology platform, Infosario Design®. In 2014 he became a Managing Director in QuintilesIMS (now IQVIA) Consulting Services and then a Senior Vice-President in IQVIA Design & Delivery Innovation, leading the Strategic Drug Development business unit. The unit supports biopharma companies to design integrated development, regulatory, and commercial strategies for their assets and due diligence activities. He also was one of the founding leaders of IQVIA’s Cell and Gene Therapy group.
Rick now is the founder and Managing Director of Pharma Design Solutions, Ltd., his consultancy practice, supporting senior biopharmaceutical executives with corporate organizational aspirations and technology companies interested in improving R&D productivity in the pharmaceutical industry.